Hui K. Gan

145 Studley Road
Heidelberg, VIC 3084, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 158 publications

Established Prognostic Scores Predict Screen Failure But Not Post-Enrollment Outcomes in Phase 1 Oncology Trials: A Single Centre Retrospective Audit.

Established Prognostic Scores Predict Screen Failure But Not Post-Enrollment Outcomes in Phase 1 Oncology Trials: A Single Centre Retrospective Audit.

Journal: Asia-Pacific journal of clinical oncology

Published: June 19, 2026

From data silos to integrated diagnosis: multimodal machine learning in glioblastoma.

From data silos to integrated diagnosis: multimodal machine learning in glioblastoma.

Journal: Frontiers in oncology

Published: June 18, 2026

Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator.

Monitoring glioblastoma dynamics during chemoradiation on the 1.5 T magnetic resonance imaging-linear accelerator.

Journal: Clinical and translational radiation oncology

Published: May 22, 2026

Phase I/II Double-Blind, Randomized Controlled Trial of Medicinal Cannabis on Quality of Life and Symptoms in Advanced Cancer: RESONANCE Trial Protocol.

Phase I/II Double-Blind, Randomized Controlled Trial of Medicinal Cannabis on Quality of Life and Symptoms in Advanced Cancer: RESONANCE Trial Protocol.

Journal: Clinical therapeutics

Published: January 29, 2026

Salvage therapies for recurrent grade 4 IDH-wildtype glioma: a BRAIN Registry analysis of real-world treatment patterns.

Salvage therapies for recurrent grade 4 IDH-wildtype glioma: a BRAIN Registry analysis of real-world treatment patterns.

Journal: Journal of neuro-oncology

Published: December 23, 2025

Clinical outcomes and quality of life in glioblastoma patients treated with MR-guided adaptive radiotherapy using a 1.5 T MR-Linac in an Australian setting.

Clinical outcomes and quality of life in glioblastoma patients treated with MR-guided adaptive radiotherapy using a 1.5 T MR-Linac in an Australian setting.

Journal: Clinical and translational radiation oncology

Published: December 11, 2025

A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma.

A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 04, 2025

Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-Oncology.

Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-Oncology.

Journal: Asia-Pacific journal of clinical oncology

Published: October 26, 2025

Altered Abundance of Barrier-Related Proteins in Brain Microvascular Endothelial Cells of the GL261 Mouse Model of Glioblastoma.

Altered Abundance of Barrier-Related Proteins in Brain Microvascular Endothelial Cells of the GL261 Mouse Model of Glioblastoma.

Journal: Molecular pharmaceutics

Published: October 18, 2025

Communication guidelines for healthcare professionals working with adults with changed cognitive capacity and their carers: A scoping review with implications for neuro-oncology.

Communication guidelines for healthcare professionals working with adults with changed cognitive capacity and their carers: A scoping review with implications for neuro-oncology.

Journal: Patient education and counseling

Published: October 07, 2025

A Bioimaging Study of 89Zr-Bintrafusp Alfa PET Scans in Patients with Advanced or Metastatic NSCLC Receiving Bintrafusp Alfa Alone or in Combination with Chemotherapy.

A Bioimaging Study of 89Zr-Bintrafusp Alfa PET Scans in Patients with Advanced or Metastatic NSCLC Receiving Bintrafusp Alfa Alone or in Combination with Chemotherapy.

Journal: Molecular imaging and biology

Published: September 25, 2025

Characterisation of mAb104 Antibody-Drug Conjugates Targeting a Tumour-Selective HER2 Epitope.

Characterisation of mAb104 Antibody-Drug Conjugates Targeting a Tumour-Selective HER2 Epitope.

Journal: Cancers

Published: August 21, 2025

Showing 1-12 of 158

Last Updated: 09/26/2026